Engineered for high performance, bioavailability, and lipid metabolism regulatory research.
Low-Density Lipoprotein (LDL) cholesterol homeostasis remains a critical focal point in cardiovascular therapeutics, drug screening, and metabolic health formulations. As global healthcare segments transition toward natural and bio-based pathways to complement statin regimens, manufacturers are facing unprecedented demands for standardized bioactive intermediates. The regulatory mechanisms governing cellular cholesterol uptake, PCSK9 enzyme dynamics, and hepatic bile acid synthesis require highly purified active compounds.
Phytochemical extracts play a dual role by upregulating hepatic LDL receptors (LDLR) and inhibiting HMG-CoA reductase. Compounds like Salvia miltiorrhiza extract ( Tanshinone IIA) and Epimedium Leaf Extract exhibit prominent vasoprotective and lipid-clearing profiles in preclinical assays.
Furthermore, bile acid intermediates, such as Deoxycholic Acid and Tauroursodeoxycholic Acid (TUDCA), directly govern the farnesoid X receptor (FXR) signaling pathway, regulating enterohepatic circulation and the excretion of endogenous lipids.
For global pharmaceutical purchasing directors and diagnostic reagent developers, sourcing reliable active pharmaceutical ingredients (APIs) and plant extracts is fraught with compliance challenges. Key procurement concerns include batch-to-batch consistency, heavy metal limits, pesticide residues, and verified assay values via HPLC/GC-MS analysis.
Industrial demand has surged significantly in the European Union, North America, and Asia-Pacific markets due to the rising prevalence of metabolic conditions. Buyers are demanding vertical integration—from the agricultural sourcing of raw herbs to high-precision cleanroom crystallization. The necessity for reliable supply chains is paramount, forcing manufacturers to adopt rigorous quality systems that meet or exceed regional pharmacopeia standards.
Chengdu ChenLv Herb Co.,Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Supplying global pharmaceutical, wellness, and cosmetic buyers with pure botanical ingredients and dedicated contract manufacturing.
Mapping the future of phytomedicine and lipid regulatory chemical production.
Implementing GAP-compliant agricultural sourcing for botanical targets like Epimedium leaf, Ginkgo biloba, and Fenugreek seed to ensure reliable chemical baselines.
Employing supercritical CO2 extraction and advanced column chromatography to isolate highly specific compounds such as Huperzine A, Artemisinin, and natural bile derivatives.
Optimizing biosynthetic pathways to mimic biological sterols, aiding in the development of targeted pharmaceutical assays that modulate receptor kinetics.
Why global pharmaceutical and health enterprises choose Chenlv Herb as their manufacturing partner.
Creative designs and high-tech extraction processes that elevate your brand and ensure premium physiological activity.
Eco-friendly packaging and optimized refining operations aligned with today's values of sustainability and carbon neutrality.
End-to-end cosmetic packaging and organic plant ingredient solutions that respect global biodiversity regulations.
Fast turnaround and flexible logistics channels to meet urgent production schedules and clinical trial timelines.
A dedicated QA/QC team supporting you through every phase of testing, from raw material validation to final COA emission.
Years of biological expertise and manufacturing operations, ensuring precision and excellence in high-purity isolation.
Leveraging natural extracts for human health, therapeutic innovations, and daily care.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have become core raw materials for supplements due to their natural, safe profiles.
READ MORE
From herbal formulas recorded in ancient books to innovative modern therapeutics, active ingredients occupy prominent positions in cardiovascular and lipid-lowering research.
READ MORE
Natural, safe, and mild botanical extracts are a favorite in the modern skincare industry, bringing innovative solutions for barrier repair and skin aging management.
READ MORE
Plant extracts show great potential in improving animal immune response, optimizing digestive function, and enhancing livestock growth yields safely.
READ MOREOne-stop OEM/ODM solutions from concept discussion to batch delivery.
Determine active compound targets and client-specific requirements.
Provide detailed financial proposals based on purity metrics and yield scale.
Formalize production agreements, target milestones, and NDA terms.
R&D team isolates and prepares high-purity laboratory trial samples.
Upon sample validation, schedule large-scale runs at our manufacturing plant.
Strict quality assurance assays run on HPLC/GC-MS, followed by COA release.
International safe transport with comprehensive regulatory clearances.
Adhering strictly to international safety, ecological, and pharmaceutical compliance rules.
Answers to critical technical and regulatory queries from pharmaceutical buyers and supply chain managers.
Our company specializes in high-purity natural and semi-synthetic intermediates. For bile acids like Deoxycholic Acid (DCA) and Tauroursodeoxycholic Acid (TUDCA), we provide standard commercial purities starting at ≥98% analyzed via High-Performance Liquid Chromatography (HPLC). We can customize purification profiles to match specific pharmacopeial standards (USP/EP) depending on client requirements.
Active constituents in Salvia miltiorrhiza, particularly Tanshinone IIA and Salvianolic Acid B, modulate lipid profiles by upregulating the expression of hepatic Low-Density Lipoprotein Receptors (LDLR) through the activation of AMPK and SREBP pathways. This increases the clearance of circulating LDL cholesterol from the blood. Furthermore, they inhibit the oxidation of LDL (ox-LDL), mitigating plaque formation in blood vessel walls.
Yes. Our extraction facilities are certified under ISO9001 and ISO22000 management programs. Many of our principal materials satisfy KOSHER, HALAL, and FDA registration criteria. We provide complete chemical assay reports, allergen certificates, and raw material tracing documents to facilitate global customs clearing and clinical regulatory clearance.
For standard stock extracts, dispatch occurs within 3-5 working days. For custom formulation development, purification runs, or specialty OEM packaging projects, the timeline averages 4 to 6 weeks. This timeline includes initial laboratory formulation, assay testing, stability analysis, and final plant production runs.
Keep up with the newest biological extract scientific reports and international events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end and new supplies enter the market, price fluctuations have become a focal point due to supply dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to present the latest extract technologies.
Our technical sales team will exhibit our newest range of physiological active ingredients, cholesterol control targets, and proprietary raw materials to global buyers attending the conference.
Highly refined plant-derived bile acids and regulatory molecules for medical research applications.
